And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept

And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept

The internal organ at risk volume (IRV) concept might improve toxicity profiles in stereotactic body radiation therapy (SBRT) for non-small cell lung cancer (NSCLC). We studied (1) clinical aspects in central vs. peripheral tumors, (2) the IRV concept in central tumors, (3) organ motion, and (4) ass...

Full description

Bibliographic Details
Main Authors: Felix-Nikolai Oschinka Jegor Habermann, Daniela Schmitt, Thomas Failing, David Alexander Ziegler, Jann Fischer, Laura Anna Fischer, Manuel Guhlich, Stephanie Bendrich, Olga Knaus, Tobias Raphael Overbeck, Hannes Treiber, Alexander von Hammerstein-Equord, Raphael Koch, Rami El Shafie, Stefan Rieken, Martin Leu, Leif Hendrik Dröge
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
NSCLC
SBRT
central tumors
clinical outcomes
clinical characteristics
motion management
Online Access:https://www.mdpi.com/2072-6694/16/1/231

Internet

https://www.mdpi.com/2072-6694/16/1/231

Similar Items